PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,000 | +66.7% | 1,815 | +83.7% | 0.00% | – |
Q2 2023 | $3,000 | +200.0% | 988 | +156.6% | 0.00% | – |
Q1 2023 | $1,000 | – | 385 | +285.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 100 | -96.7% | 0.00% | – |
Q1 2022 | $9,000 | -65.4% | 3,044 | -65.0% | 0.00% | – |
Q4 2021 | $26,000 | -49.0% | 8,705 | +20.1% | 0.00% | – |
Q3 2021 | $51,000 | -12.1% | 7,251 | +15.8% | 0.00% | – |
Q2 2021 | $58,000 | -27.5% | 6,264 | -24.6% | 0.00% | – |
Q1 2021 | $80,000 | +50.9% | 8,306 | +64.4% | 0.00% | – |
Q4 2020 | $53,000 | +10.4% | 5,053 | +7.5% | 0.00% | – |
Q3 2020 | $48,000 | -83.2% | 4,700 | -82.8% | 0.00% | – |
Q2 2020 | $285,000 | -34.3% | 27,352 | -46.9% | 0.00% | – |
Q1 2020 | $434,000 | +77.9% | 51,479 | +84.1% | 0.00% | – |
Q4 2019 | $244,000 | +86.3% | 27,960 | +129.7% | 0.00% | – |
Q3 2019 | $131,000 | +36.5% | 12,175 | +60.0% | 0.00% | – |
Q2 2019 | $96,000 | -11.1% | 7,608 | +171.3% | 0.00% | – |
Q1 2019 | $108,000 | +56.5% | 2,804 | -18.3% | 0.00% | – |
Q4 2018 | $69,000 | -72.1% | 3,431 | -36.3% | 0.00% | – |
Q3 2018 | $247,000 | -16.0% | 5,387 | +8.1% | 0.00% | – |
Q2 2018 | $294,000 | +7.7% | 4,985 | +24.0% | 0.00% | – |
Q1 2018 | $273,000 | +155.1% | 4,021 | +271.3% | 0.00% | – |
Q4 2017 | $107,000 | -72.7% | 1,083 | -66.9% | 0.00% | – |
Q3 2017 | $392,000 | +734.0% | 3,274 | +523.6% | 0.00% | – |
Q2 2017 | $47,000 | -9.6% | 525 | -62.7% | 0.00% | – |
Q1 2017 | $52,000 | +2.0% | 1,408 | -15.5% | 0.00% | – |
Q4 2016 | $51,000 | +54.5% | 1,666 | +236.6% | 0.00% | – |
Q3 2016 | $33,000 | +22.2% | 495 | -46.5% | 0.00% | – |
Q2 2016 | $27,000 | -69.3% | 925 | -69.1% | 0.00% | – |
Q1 2016 | $88,000 | +23.9% | 2,991 | +232.7% | 0.00% | – |
Q4 2015 | $71,000 | -5.3% | 899 | -9.3% | 0.00% | – |
Q3 2015 | $75,000 | -69.9% | 991 | -53.6% | 0.00% | – |
Q2 2015 | $249,000 | -78.0% | 2,138 | -55.5% | 0.00% | -100.0% |
Q1 2015 | $1,134,000 | +212.4% | 4,803 | +150.7% | 0.00% | – |
Q4 2014 | $363,000 | +41.8% | 1,916 | +78.4% | 0.00% | – |
Q3 2014 | $256,000 | +20.2% | 1,074 | -66.7% | 0.00% | – |
Q2 2014 | $213,000 | -57.0% | 3,225 | -32.1% | 0.00% | – |
Q1 2014 | $495,000 | -85.0% | 4,750 | -85.1% | 0.00% | -100.0% |
Q4 2013 | $3,304,000 | +7.7% | 31,909 | -44.2% | 0.00% | 0.0% |
Q3 2013 | $3,069,000 | +70.8% | 57,200 | +41.2% | 0.00% | 0.0% |
Q2 2013 | $1,797,000 | – | 40,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
Leap Investments LP | 29,100 | $370,000 | 0.50% |
Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |